GO:0051180 vitamin transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051180 vitamin transport describes the directed movement of vitamins into, out of, or within cells by transporters or pores.
• Vitamins are unrelated organic substances required in trace amounts for normal metabolism, and their transport is essential for systemic homeostasis.
• Specific transporters mediate uptake of water-soluble vitamins such as thiamine via SLC19A3 (ThTR-2) and vitamin C via SVCT1 (SLC23A1).
• Fat-soluble vitamins A and E require membrane receptors and transporters for intestinal absorption and tissue delivery.
• In the brain, dedicated transport systems maintain vitamin B and E homeostasis, and their dysfunction is linked to neurological disease.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of vitamin transport genes in human cells and organoids.
Description
Vitamin transport (GO:0051180) is the biological process by which vitamins are moved into, out of, or within a cell, or between cells, through the action of transporters or pores. Vitamins are a diverse group of organic compounds that occur in foods in small amounts and are necessary in trace quantities for normal metabolic functioning of the body. Because most vitamins cannot be synthesized endogenously in sufficient amounts, their uptake and distribution depend on dedicated membrane transport systems. This GO term captures the directed movement of these micronutrients across biological membranes and between cellular compartments. Research on vitamin transport is important because it underpins nutritional status, metabolic regulation, and tissue-specific delivery of cofactors and antioxidants. For example, intestinal absorption of vitamin E and carotenoids requires specific membrane proteins that regulate how much of these lipids enter the body. Similarly, vitamin A and its derivatives rely on membrane receptors and transporters for uptake, storage, and delivery to the eye and other tissues. In the brain, transport systems for vitamins B and E maintain homeostasis, and their disruption can contribute to neurological dysfunction. From a methodological perspective, vitamin transport is studied using transporter-specific assays, structural biology, and genetic perturbation. The thiamine transporter ThTR-2 (SLC19A3) is a target for drug-nutrient interactions, and its inhibition by prescription drugs can alter thiamine availability. Structural studies of the mammalian vitamin C transporter SVCT1 have revealed the basis of substrate recognition and transport. These examples illustrate how GO:0051180 connects molecular transport mechanisms to physiology and disease.
vitamin transport At A Glance
| GO ID | GO:0051180 |
|---|---|
| GO term | vitamin transport |
| Ontology | biological_process |
| Synonym | vitamin or cofactor transport |
| Major function | Directed movement of vitamins across membranes via transporters or pores |
| Definition source | QuickGO |
| Example transporters | SLC19A3 (thiamine), SVCT1 (vitamin C), vitamin A and E transport proteins |
| Physiological context | Intestinal absorption, brain homeostasis, tissue delivery |
| Research relevance | Nutrition, drug-nutrient interactions, neurological and metabolic disease |
What Is GO:0051180?
GO:0051180 vitamin transport is defined as the directed movement of vitamins into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. A vitamin is one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. The synonym vitamin or cofactor transport reflects the broader role of these processes in delivering essential cofactors and micronutrients.
Why Is vitamin transport Important in Cell Biology?
Vitamin transport is essential because it determines the bioavailability and tissue distribution of micronutrients that cannot be synthesized in sufficient quantities by the body. Transporters and receptors for vitamins A, B, C, and E control intestinal absorption, cellular uptake, and delivery to target organs such as the eye and brain. Dysregulation or inhibition of these transport systems can lead to vitamin deficiency, drug-nutrient interactions, and disease. Therefore, understanding GO:0051180 provides a mechanistic basis for nutrition, pharmacology, and therapeutic development.
• Vitamin transport maintains systemic and cellular homeostasis of essential micronutrients.
• Intestinal absorption of fat-soluble vitamins A and E depends on specific membrane proteins and receptors.
• The thiamine transporter ThTR-2 (SLC19A3) is a target for prescription drug inhibitors, causing drug-nutrient interactions.
• Vitamin C transport by SVCT1 is critical for antioxidant defense and metabolic functions.
• Vitamin A transporters are required for visual function and delivery of retinoids to the eye.
• Brain vitamin B and E transport systems protect against neurological dysfunction.
• Bacterial vitamin transport systems contribute to microbial metabolism and pathogenesis.
• Genetic variation in vitamin transport genes can influence nutritional status and disease risk.
• CRISPR-based models allow causal testing of transporter genes in human cells.
• Targeting vitamin transport pathways may offer therapeutic strategies for deficiency and metabolic disorders.
What Happens During vitamin transport?
Substrate recognition at the membrane
In simple terms: The transporter first recognizes and binds its specific vitamin cargo at the cell membrane.
Vitamin transport begins with substrate recognition by a membrane transporter or receptor. For vitamin C, the mammalian SVCT1 transporter specifically recognizes and binds ascorbate, as revealed by structural studies. Vitamin A and its derivatives are recognized by membrane receptors and transporters that mediate uptake and transport. In the intestine, proteins involved in fat-soluble vitamin and carotenoid transport recognize their lipid substrates to facilitate absorption. This step ensures selectivity so that the correct vitamin is moved across the membrane.
Translocation across the membrane
In simple terms: After binding, the transporter moves the vitamin across the membrane into or out of the cell.
Following recognition, the transporter undergoes conformational changes that translocate the vitamin across the lipid bilayer. SVCT1 mediates sodium-dependent transport of vitamin C, and its structure provides insight into the translocation mechanism. Vitamin E intestinal absorption requires membrane transport across the enterocyte, a process regulated by specific proteins. Similarly, vitamin A transport across intestinal cells involves membrane receptors and transporters that move retinoids into and out of the enterocyte. These translocation events are directed and energy-dependent or coupled to ion gradients depending on the transporter.
Intracellular distribution and storage
In simple terms: Once inside the cell, vitamins are distributed to where they are needed or stored.
After entering the cell, vitamins are directed to specific compartments or storage forms. Vitamin A is stored as retinyl esters and later mobilized for delivery to tissues such as the eye. Vitamin E is distributed within membranes and lipoproteins after intestinal absorption. In the brain, transport systems maintain vitamin B and E homeostasis by regulating their movement into and within neural cells. This intracellular phase ensures that vitamins reach their sites of metabolic action.
Tissue delivery and systemic homeostasis
In simple terms: Transporters also move vitamins between cells and organs to maintain whole-body balance.
Vitamin transport extends beyond single cells to systemic delivery. Vitamin A transporters mediate uptake, storage, and transport to the eye for visual function. In the brain, dedicated transport mechanisms maintain vitamin B and E homeostasis, highlighting the importance of blood-brain barrier transport. Intestinal absorption of fat-soluble vitamins and carotenoids determines how much enters the circulation. In bacteria, vitamin transport systems support microbial metabolism and interactions with the environment. Together, these processes maintain systemic vitamin homeostasis.
Regulation and drug interactions
In simple terms: Vitamin transport can be turned up or down, and some drugs interfere with it.
Vitamin transport is regulated and can be inhibited by exogenous compounds. The thiamine transporter ThTR-2 (SLC19A3) is inhibited by prescription drugs, leading to drug-nutrient interactions that may affect thiamine status. Vitamin E intestinal absorption is regulated by membrane transport across the enterocyte, which can be influenced by dietary and physiological factors. These regulatory and inhibitory mechanisms are important for understanding nutrient-drug interactions and for designing therapeutic interventions.
Key Genes Involved in GO:0051180 vitamin transport
The following genes and proteins are experimentally implicated in vitamin transport processes and are commonly studied in this field.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC19A3 (ThTR-2) | Thiamine transporter | Target of prescription drug inhibitors; drug-nutrient interactions |
| SLC23A1 (SVCT1) | Vitamin C (ascorbate) transporter | Structural basis of vitamin C recognition and transport |
| RBP4 | Vitamin A transport protein | Retinol delivery to tissues including the eye |
| STRA6 | Vitamin A membrane receptor | Cellular uptake of retinol for storage and delivery |
| TTR | Transports retinol-binding protein-vitamin A complex | Systemic vitamin A distribution |
| SCARB1 | Vitamin E and carotenoid transport | Intestinal absorption of fat-soluble vitamins |
| NPC1L1 | Intestinal sterol and vitamin E uptake | Fat-soluble vitamin absorption |
| ABCA1 | Lipoprotein-mediated vitamin E transport | Vitamin E distribution |
| CUBAM (AMN/CUBN) | Intestinal vitamin B12 uptake | Vitamin B12 absorption |
| SLC46A1 (PCFT) | Folate transport | Intestinal folate absorption |
| SLC19A1 (RFC) | Reduced folate carrier | Folate transport |
| SLC52A2 (RFVT2) | Riboflavin transport | Vitamin B2 homeostasis |
| SLC52A3 (RFVT3) | Riboflavin transport | Vitamin B2 homeostasis |
| SLC5A6 (SMVT) | Biotin and pantothenate transport | Water-soluble vitamin uptake |
| SLC22A5 (OCTN2) | Carnitine and vitamin transport | Nutrient transport |
| LRP2 (Megalin) | Vitamin D and A uptake | Renal and tissue vitamin transport |
| CUBN | Vitamin B12 and D uptake | Cubilin-mediated vitamin transport |
How Is vitamin transport Regulated?
Vitamin transport is regulated at multiple levels to maintain homeostasis. The thiamine transporter ThTR-2 (SLC19A3) can be inhibited by prescription drugs, representing a form of pharmacological regulation that alters thiamine availability. Intestinal absorption of vitamin E is regulated by membrane transport across the enterocyte, which responds to physiological and dietary factors. In the brain, transport systems for vitamins B and E are regulated to maintain homeostasis, and their dysfunction can contribute to neurological disease. Vitamin A transport and storage are regulated by membrane receptors and transporters that control uptake and delivery to target tissues. These regulatory mechanisms ensure that vitamin levels are kept within physiological ranges.
vitamin transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A3 (ThTR-2) | Drug-nutrient interactions, thiamine deficiency | Knockout and point-mutation cell lines for transport assays |
| SLC23A1 (SVCT1) | Vitamin C transport and antioxidant defense | Knockout cells and structural studies |
| STRA6 | Visual dysfunction and vitamin A delivery | Knock-in and knockout models for retinoid transport |
| SCARB1 | Fat-soluble vitamin absorption | Intestinal cell models with knockout |
| SLC52A2/SLC52A3 | Riboflavin transport and neurological disease | Knockout and overexpression models |
Neurological dysfunction and vitamin transport
The brain depends on dedicated transport systems for vitamins B and E to maintain homeostasis. Disruption of these transport mechanisms can lead to neurological dysfunction, as vitamins are essential for neuronal metabolism and antioxidant defense. Thiamine transporter SLC19A3 (ThTR-2) is particularly relevant because its inhibition by prescription drugs can reduce thiamine availability, potentially affecting brain function. These findings link GO:0051180 to neurodegenerative and neurological conditions.
Visual function and vitamin A transport
Vitamin A transporters are essential for visual function, as they mediate uptake, storage, and transport of retinoids to the eye. Membrane receptors for dietary vitamin A uptake and delivery to the eye are required for the visual cycle. Defects in these transport processes can impair vision and contribute to retinal disease. This demonstrates the importance of GO:0051180 in sensory organ function.
Drug-nutrient interactions and metabolic disease
Prescription drugs can inhibit the thiamine transporter ThTR-2 (SLC19A3), leading to drug-nutrient interactions that may cause thiamine deficiency. Such interactions are clinically relevant because thiamine is critical for energy metabolism. Additionally, intestinal absorption of fat-soluble vitamins and carotenoids is regulated by specific transport proteins, and their dysfunction can affect nutritional status. These examples highlight how vitamin transport impacts pharmacology and metabolic health.
Bacterial vitamin transport and infection
Vitamin transport in bacteria supports microbial metabolism and can influence host-microbe interactions. Bacterial transport systems for vitamins are essential for their growth and survival in diverse environments. Understanding these processes may inform the development of antimicrobial strategies targeting vitamin uptake. Thus, GO:0051180 is relevant to microbiology and infectious disease research.
From vitamin transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC19A3 affect thiamine uptake? | CRISPR knockout in human cell lines |
| How does SVCT1 recognize vitamin C? | Point-mutation and structural studies |
| Does STRA6 mutation impair vitamin A delivery? | Knock-in of patient variants |
| Can overexpression of SCARB1 increase vitamin E uptake? | Overexpression cell models |
| What is the role of brain vitamin B transporters? | Knockout and tagged knock-in in neuronal cells |
| Do bacterial vitamin transporters affect growth? | Knockout in bacterial models |
How to Study the vitamin transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled vitamin uptake | Transport activity | Characterizing SLC19A3 and SVCT1 function |
| Cryo-EM / crystallography | Transporter structure | Mechanism of vitamin recognition |
| CRISPR knockout | Loss-of-function phenotype | Testing causal role of transporters |
| Knock-in of patient variants | Variant-specific transport defects | Modeling disease-associated mutations |
| Overexpression | Gain-of-function transport | Enhancing vitamin uptake |
| RNA-seq | Transporter expression profiles | Tissue-specific vitamin transport |
| Proteomics | Protein abundance and interactions | Identifying transport complexes |
| Drug inhibition assays | Inhibitor sensitivity | Drug-nutrient interaction studies |
Transport assays
Transport assays measure the uptake or efflux of radiolabeled or fluorescent vitamins in cells expressing specific transporters. These assays are used to characterize the function of SLC19A3 (ThTR-2) and SVCT1 and to test inhibition by drugs. They provide direct functional evidence for GO:0051180 activity.
Structural biology
Structural studies, such as cryo-EM or crystallography, reveal how transporters recognize and translocate vitamins. The structure of SVCT1 provided insight into vitamin C recognition and transport. Similar approaches can be applied to other vitamin transporters to understand mechanism.
Genetic perturbation
CRISPR knockout, knock-in, and overexpression models are used to test the causal role of vitamin transport genes. For example, knockout of SLC19A3 can reveal its importance in thiamine uptake, and overexpression of SCARB1 can enhance vitamin E absorption. These methods link genotype to transport phenotype.
Expression profiling
RNA-seq and proteomics can profile the expression of vitamin transporters across tissues and conditions. Such studies help identify which transporters are active in specific contexts, such as intestinal absorption or brain homeostasis. Expression data complement functional assays for GO:0051180.
How CRISPR Can Be Used to Study GO:0051180 vitamin transport
Knockout
CRISPR knockout of vitamin transport genes such as SLC19A3 or SLC23A1 allows researchers to determine whether a specific transporter is required for vitamin uptake. Knockout cell lines can be used in transport assays to measure loss of function and to validate drug-nutrient interactions. This approach provides causal evidence for the role of a gene in GO:0051180.
Point Mutation
Point mutations can be introduced into vitamin transporter genes to model patient variants or to dissect substrate recognition. For example, mutations in SVCT1 can reveal residues critical for vitamin C binding and transport. Such models help link specific amino acids to transport function.
Knock-in
Knock-in of tagged or patient-derived variants enables tracking of transporter localization and function. Tagged knock-in of vitamin A transporters can reveal their trafficking and delivery to the eye. This approach is useful for studying transport dynamics in physiologically relevant contexts.
Overexpression
Overexpression of vitamin transporters such as SCARB1 can increase cellular uptake of fat-soluble vitamins and carotenoids. Overexpression models are valuable for gain-of-function studies and for producing cells with enhanced vitamin transport capacity.
How EDITGENE Supports vitamin transport Research
Researchers studying vitamin transport-related genes often need to determine whether a candidate gene is causally involved in vitamin uptake, distribution, or homeostasis. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to test these hypotheses in relevant human cell types.
Contact EDITGENE today to design your custom CRISPR model for vitamin transport research.
Frequently Asked Questions About vitamin transport
What is GO:0051180 vitamin transport?
GO:0051180 vitamin transport is the biological process of moving vitamins into, out of, or within cells by transporters or pores.
What genes are involved in vitamin transport?
Genes include SLC19A3 (thiamine), SLC23A1 (vitamin C), STRA6 and RBP4 (vitamin A), and SCARB1 (vitamin E).
Why is vitamin transport important?
It maintains vitamin homeostasis, supports metabolism, and prevents deficiency-related disease.
How is vitamin transport studied?
Using transport assays, structural biology, and CRISPR genetic perturbation.
What diseases are linked to vitamin transport defects?
Neurological dysfunction, visual impairment, and drug-nutrient interactions.
Which transporter handles vitamin C?
SVCT1 (SLC23A1) mediates vitamin C transport.
Which transporter is targeted by prescription drugs?
ThTR-2 (SLC19A3) is inhibited by some prescription drugs.
How does vitamin A reach the eye?
Membrane receptors and transporters mediate uptake, storage, and delivery of vitamin A to the eye.
Is vitamin transport relevant in bacteria?
Yes, bacterial vitamin transport supports microbial metabolism.
Can CRISPR be used to study vitamin transport?
Yes, knockout, knock-in, and overexpression models enable causal testing of transport genes.
Conclusion
GO:0051180 vitamin transport is a fundamental biological process that governs the movement of essential micronutrients across membranes and between cells. It relies on specific transporters and receptors for vitamins A, B, C, and E, and its dysfunction is linked to neurological, visual, and metabolic disorders. Understanding these mechanisms is critical for nutrition, pharmacology, and therapeutic development. CRISPR-based cell models provide powerful tools to dissect the causal roles of vitamin transport genes. By combining knockout, point mutation, knock-in, and overexpression strategies, researchers can uncover new insights into vitamin homeostasis and disease.
References
- 1. Reboul E. 2019. Vitamin E intestinal absorption: Regulation of membrane transport across the enterocyte.. IUBMB Life 71(4):416-423 PMID: 30308094
- 2. Vora B et al.. 2020. Drug-nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3).. Am J Clin Nutr 111(1):110-121 PMID: 31764942
- 3. Spector R et al.. 2007. Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E.. J Neurochem 103(2):425-38 PMID: 17645457
- 4. Sun H. 2012. Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives.. Biochim Biophys Acta 1821(1):99-112 PMID: 21704730
- 5. Wang M et al.. 2023. Structural basis of vitamin C recognition and transport by mammalian SVCT1 transporter.. Nat Commun 14(1):1361 PMID: 36914666
- 6. Reboul E. 2023. Proteins involved in fat-soluble vitamin and carotenoid transport across the intestinal cells: New insights from the past decade.. Prog Lipid Res 89:101208 PMID: 36493998
- 7. Martin Ask N et al.. 2021. Vitamin A Transporters in Visual Function: A Mini Review on Membrane Receptors for Dietary Vitamin A Uptake, Storage, and Transport to the Eye.. Nutrients 13(11) PMID: 34836244
- 8. Gershanovich VN. 1980. [Vitamin transport in bacteria].. Usp Sovrem Biol 89(2):205-21 PMID: 6446814
